All Articles

Vantage Biosciences has completed enrollment for its oral drug, oruvestat, a potential game-changer for early diabetic retinopathy. This could replace invasive injections.

Gen Z spends big on self-care but avoids the doctor's office, turning to AI first. This trend creates a wellness paradox, straining the health system.

Founder Remy Trafelet returns as CEO of Hazeltree, joined by new operations and product chiefs to accelerate AI integration and solidify its market lead.

Q2 Metals' appointment of a seasoned lithium executive signals a crucial shift from discovery to development for its massive Cisco project in Québec.

By partnering with major CROs, Revolune is tackling a key bottleneck in advanced tissue analysis. This new ecosystem could change how labs of all sizes innovate.

A new pheromone-infused, eco-friendly litter signals a major shift in pet care, where emotional well-being is as important as cleanliness.

LivePerson's urgent call for a 'FOR' vote on its SoundHound AI merger is more than corporate messaging—it's a plea for survival, revealing a high-stakes network play.

Oblenio Bio's LBL-051 enters human trials, offering hope for a true "immune reset" and drug-free remission for severe autoimmune disease patients.

As Two Prime hosts leaders from Kraken, U.S. Bank, and Tether, the real work begins: integrating digital assets into the global financial system.

A new partnership signals a major shift in U.S. space defense, where on-demand orbital logistics and startup innovation are the ultimate strategic assets.

Hatz AI's new Activate platform isn't just software; it's critical infrastructure for the MSP channel, aiming to solve the chaotic, risky state of SMB AI adoption.

KeyCorp's acquisition of Clearwater UK isn't just a deal; it's a strategic move to dominate the transatlantic middle-market M&A landscape. What does this mean for clients and competitors?

A new partnership between a CPG giant and a gig economy platform isn't just a marketing stunt; it's a blueprint for the future of consumer engagement.

Sage Dental's major acquisition in Tampa isn't just a deal; it's a look into the future of healthcare—a story of scale, strategy, and the test of local trust.

As firms drown in complex trade rules, a new AI solution from Descartes promises to automate compliance, maximize duty savings, and reduce costly errors.

A deep dive into Westlake's stunning Q2 turnaround, where a $600M strategic plan met global supply shocks, creating a powerful recovery amid market chaos.

Enpro's Q2 results reveal a powerful strategy: leveraging the AI-driven semiconductor boom to deliver record growth while navigating a mixed industrial landscape.

Westlake Chemical Partners reports flat net income but a massive cash flow jump, proving its post-turnaround efficiency and fortifying its reputation for stability.

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

TelyRx just revamped its entire platform based on patient feedback. In a market with giants like Amazon, is a bet on transparency and convenience the winning move?